Sionna Therapeutics, Inc. (SION) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 154K | 152K | 0 | 147K | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | -154K | -152K | 0 | -147K | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - |
| Operating Expenses | 29.45M | 23.46M | 23.8M | 21.76M | 19.66M | 18.13M | 27.98M | 12.6M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 10.48M | 9.87M | 7.24M | 6.52M | 5.56M | 3.88M | 4.16M | 2.71M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - |
| Research & Development | 18.96M | 15.17M | 16.04M | 15.38M | 13.67M | 14.25M | 24.58M | 9.89M |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 520K | -147K | 431K | 0 | -756K | 0 |
| Operating Income | -29.6M | -23.61M | -23.8M | -21.91M | -19.66M | -18.13M | -27.98M | -12.6M |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -50.56% | -30.22% | 14.93% | - | - | -43.97% | - | - |
| EBITDA | -29.45M | -24.29M | -23.29M | -21.76M | -19.23M | -17.97M | -27.82M | -12.43M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -53.14% | -35.2% | 16.29% | - | - | -44.49% | - | - |
| D&A (Non-Cash Add-back) | 154K | -678K | 520K | 147K | 431K | 167K | 169K | 161K |
| EBIT | -29.6M | -17.26M | -23.8M | -18.07M | -19.66M | -18.13M | -27.98M | -12.6M |
| Net Interest Income | 2.82M | 3.17M | 3.46M | 3.67M | 3M | 2.12M | 2.35M | 553K |
| Interest Income | 2.82M | 3.17M | 3.46M | 3.67M | 3M | 2.12M | 2.35M | 553K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.82M | 3.17M | 3.53M | 3.84M | 3.18M | 2.29M | 2.54M | 719K |
| Pretax Income | -26.78M | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M | -25.44M | -11.88M |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -26.78M | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M | -25.44M | -11.88M |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | -62.47% | -28.98% | 20.29% | - | - | -33.45% | - | - |
| Net Income (Continuing) | -26.78M | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M | -25.44M | -11.88M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 | -0.36 | -0.58 | -0.27 |
| EPS Growth % | -60.51% | -28.06% | 20.69% | - | - | -33.43% | - | - |
| EPS (Basic) | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 | -0.36 | -0.58 | -0.27 |
| Diluted Shares Outstanding | 44.92M | 39.96M | 44.46M | 44.13M | 44.09M | 44.12M | 44.12M | 44.12M |
| Basic Shares Outstanding | 44.92M | 39.96M | 44.46M | 44.13M | 44.09M | 44.12M | 44.12M | 44.12M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |